A veteran ibogaine/psychedelic access provision is formally introduced or offered as an NDAA/VA amendment within 10 weeks, citing Stanford ibogaine data.

Within the next ten weeks, at least one member of Congress is expected to formally propose adding a provision to a major defense or veterans' affairs bill that would expand veterans' access to ibogaine (a powerful plant-based psychedelic) or other psychedelic therapies. This push is fueled by recent Stanford University research showing ibogaine may help veterans with opioid addiction and PTSD (post-traumatic stress disorder), and by renewed public attention to veterans' mental health. Getting it formally introduced is step one — passing is a much longer road.

Iran withdrawal creates a veteran-mental-health news peg. Stanford's ibogaine-opioid-PTSD work gives bipartisan cover. Cosponsors will move — that's how these windows work.